Exogenous calmodulin potentiates vasodilation elicited by phospholipid- associated VIP in vivo

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Ikezaki, Hiroyuki ^a,b   Patel, Manisha ^a,c   Önyüksel, Hayat ^a,c   Akhter, Syed R ^a,b   Gao, Xiao Pei ^a   Rubinstein, Israel ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c University of Illinois at Chicago   (United States)

Author keywords

Arteriole; Calmodulin inhibitors; Hamster; Microcirculation; Nitric oxide; Sterically stabilized liposomes; Vasoactive intestinal peptide; Vasomotor tone

Indexed keywords

CALMODULIN; LIPOSOME; NITRIC OXIDE; PHOSPHOLIPID; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ARTICLE; CHEEK POUCH; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; VASODILATATION; VASOMOTOR REFLEX;

EID: 0032968342     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.1999.276.5.r1359     Document Type: Article

References (40)

1. Ahlijanian, M. K., and D. M. F. Cooper. Antagonism of calmodulin-stimulated adenyl cyclase by trifluoperazine, calmidazolium and W-7 in rat cerebellar membranes. J. Pharmacol. Exp. Ther. 241: 407-414, 1987.
2. Alkan-Önyüksel, H., H. Ikezaki, M. Patel, and I. Rubinstein. Anovel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo. Pharm. Res. 16: 155-160, 1999.
3. Andersson, M., M. Carlquist, M. Maletti, and J.-C. Marie. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity protein for VIP, shown to be identical to calmodulin. FEBS Lett. 318: 35-40, 1993.
4. Brizzolara, A. L., and G. Burnstock. Endothelium-dependent and endothelium-independent vasodilatation of the hepatic artery of the rabbit. Br. J. Pharmacol. 103: 1206-1212, 1991.
5. Chiba, K., S. Kurashima, and T. Mohri. Interaction between lipids and bovine brain calmodulin: lysophosphatidylcholine-induced conformational change. Life Sci. 47: 953-960, 1990.
6. Cox, J. A., M. Comte, J. E. Fitton, and W. F. DeGrado. The interaction of calmodulin with amphiphilic peptides. J. Biol. Chem. 260: 2527-2534, 1985.
7. Dawson, R. A., and S. MacNeil. Mitogenic role for extracellular calmodulin-like activity in normal human umbilical vein endothelial cells. Br. J. Haematol. 82: 151-160, 1992.
8. Doyle, M. P., and B. R. Duling. Acetylcholine induces conducted vasodilation by nitric oxide-dependent and -independent mechanisms. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H1364-H1371, 1997.
9. Gao, X.-p., Y. Noda, I. Rubinstein, and S. Paul. Vasoactive intestinal peptide encapsulated in liposomes: effects of systemic arterial blood pressure. Life Sci. 54: PL247-PL252, 1994.
10. G-monomethyl arginine in endothelium-denuded vessels. Br. J. Pharmacol. 102: 567-572, 1991.
11. 2+ is absent. J. Biol. Chem. 270: 6741-6750, 1995.
12. Gololobov, G., Y. Noda, S. Sherman, I. Rubinstein, J. Baranowska-Kortylewicz, and S. Paul. Stabilization of vasoactive intestinal peptide by lipids. J. Pharmacol. Exp. Ther. 285: 753-758, 1998.
13. Gulbenkian, S., O. S. Opgaard, R. Ekman, N. C. Andrade, J. Wharton, J. M. Polak, J. Queiroz e Melo, and L. Edvinsson. Peptidergic innervation of human epicardial coronary arteries. Circ. Res. 73: 579-588, 1993.
14. Houston, D. S., C. W. Carson, and C. T. Esmon. Endothelial cells and extracellular calmodulin inhibit monocyte tumor necrosis factor release and augment neutrophil elastase release. J. Biol. Chem. 272: 11778-11785, 1997.
15. Huang, M., and O. P. Rorstad. VIP receptors in mesenteric and coronary arteries: a radioligand binding study. Peptides 8: 477-485, 1987.
16. Ignarro, L. J., R. E. Byrns, G. M. Buga, and K. S. Wood. Mechanisms of endothelium-dependent vascular smooth muscle relaxation elicited by bradykinin and VIP. Am. J. Physiol. 253 (Heart Circ. Physiol. 22): H1074-H1082, 1987.
17. Ikezaki, H., H. Alkan-Önyüksel, and I. Rubinstein. Liposomal VIP attenuates phenylephrine-and angiotensin II-induced vasoconstriction in vivo. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R588-R595, 1998.
18. Ikezaki, H., S. Paul, H. Alkan-Önyüksel, M. Patel, X.-p. Gao, and I. Rubinstein. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. Am. J. Physiol. 275 (Regulatory Integrative Comp. Physiol. 44): R56-R62, 1998.
19. Illiano, S., T. Nagao, and P. M. Vanhoutte. Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. Br. J. Pharmacol. 107: 387-392, 1992.
20. MacNeil, S., R. A. Dawson, G. Crocker, C. H. Barton, L. Hanford, R. Metcalfe, M. McGurk, and D. S. Munro. Extracellular calmodulin and its association with epidermal growth factor in normal human body fluids. J. Endocrinol. 118: 501-509, 1988.
21. 2+-calmodulin. Biochemistry 35: 14651-14658, 1996.
22. Mayhan, W. G., and I. Rubinstein. Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: reversal by L-arginine. Biochem. Biophys. Res. Commun. 184: 1372-1377, 1992.
23. Moncada, S., and A. Higgs. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329: 2002-2012, 1993.
24. Nagano, T., S. Illiano, and P. M. Vanhoutte. Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery. Br. J. Pharmacol. 107: 382-386, 1992.
25. Noda, Y., J. Rodriguez-Sierra, J. Liu, D. Landers, A. Mori, and S. Paul. Partitioning of vasoactive intestinal polypeptide into lipid bilayers. Biochim. Biophys. Acta 1191: 324-330, 1994.
26. O'Neil, K. T., and W. F. DeGrado. How calmodulin binds its targets: sequence independent recognition of amphiphilic α-helices. Trends Biochem. Sci. 15: 59-64, 1990.
27. Patel, M., I. Rubinstein, H. Ikezaki, and H. Alkan-Önyüksel. A novel bioactive formulation of vasoactive intestinal peptide in micelles (Abstract). Pharm. Res. 14: S153, 1997.
28. Patel, M., I. Rubinstein, H. Ikezaki, H. Alkan-Önyüksel. Simplified preparation of vasoactive intestinal peptide in sterically stabilized liposomes. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24: 913-914, 1997.
29. Paul, S., and M. Ebadi. Vasoactive intestinal peptide: its interactions with calmodulin and catalytic antibodies. Neurochem. Int. 23: 197-214, 1993.
30. 2: apparent correlation with in vivo modulation of mediator release. Proc. Natl. Acad. Sci. USA 85: 2315-2319, 1988.
31. Robinson, R. M., E. W. Blakeney, Jr., and W. L. Mattice. Lipid-induced conformational changes in glucagon, secretin, and vasoactive intestinal peptide. Biopolymers 21: 1217-1228, 1982.
32. Rubinstein, I., and W. G. Mayhan. L-Arginine dilates cheek pouch arterioles in hamsters with hereditary cardiomyopathy. J. Lab. Clin. Med. 125: 313-318, 1995.
33. Rubinstein, I., M. Patel, and H. Önyüksel. Calmodulin amplifies vasoactive intestinal peptide conformational transition in sterically stabilized micelles (Abstract). PharmSci 1: S-229, 1998.
34. Rubinstein, I., T. Yong, S. I. Rennard, and W. G. Mayhan. Cigarette smoke extract attenuates endothelium-dependent arteriolar dilatation in vivo. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H1913-H1918, 1991.
35. Séjourné, F., I. Rubinstein, H. Suzuki, and H. Alkan-Önyüksel. Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes. Pharm. Res. 14: 362-365, 1997.
36. Séjourné, F., H. Suzuki, H. Alkan-Önyüksel, X.-p. Gao, H. Ikezaki, and I. Rubinstein. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R287-R292, 1997.
37. Stallwood, D., C. H. Brugger, B. A. Baggenstoss, P. M. Stemmer, H. Shiraga, D. F. Landers, and S. Paul. Identity of a membrane-bound vasoactive intestinal peptide-binding protein with calmodulin. J. Biol. Chem. 267: 19617-19621, 1992.
38. Suzuki, H., X.-p. Gao, C. O. Olopade, and I. Rubinstein. Neutral endopeptidase modulates vasoactive intestinal peptide-induced vasodilation in situ. Am. J. Physiol. 271 (Regulatory Integrative Comp. Physiol. 40): R393-R397, 1996.
39. Suzuki, H., Y. Noda, X.-p. Gao, F. Séjourné, H. Alkan-Önyüksel, S. Paul, and I. Rubinstein. Encapsulation of vasoactive intestinal peptide into liposomes restores vasorelaxation in hypertension in situ. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H282-H287, 1996.
40. Suzuki, H., Y. Noda, S. Paul, X.-p. Gao, and I. Rubinstein. Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilation in vivo. Life Sci. 57: 1451-1457, 1995.